We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Traditional Chinese Medicines Could Be Dangerous

By HospiMedica International staff writers
Posted on 25 Apr 2012
A study that analyzed samples of traditional Chinese medicines (TCMs) using DNA sequencing technology revealed that some contained potentially toxic plant ingredients, allergens, and traces of endangered animals.

Researchers at Murdoch University (Perth, Australia) analyzed TCM’s seized by the Australian Customs and Border Protection Service, and the International Wildlife Trade Section; the 15 TCM samples came in powder form, tablets, capsules, flakes, and herbal teas. More...
Using second-generation, high-throughput sequencing (HTS) of DNA, the researchers genetically audited organic ingredients within complex TCMs. Comparison of DNA sequence data to reference databases revealed the presence of 68 different plant families and included genera, such as Ephedra and Asarum, that are potentially toxic if the wrong dosage is taken, but none of them actually listed concentrations on the packaging.

The researchers also found traces from trade restricted animals that are classified as vulnerable, endangered, or critically endangered, including the Asian black bear (Ursus thibetanus) and Saiga antelope (Saiga tatarica). Another aspect of TCMs is product mislabeling. Consumers are not aware that the products contain hazardous ingredients, such as animal DNA and potential allergens like soy or nuts. For example, a product labeled as 100% Saiga antelope was found to contain considerable quantities of goat and sheep DNA. Another product, Mongnan Tianbao pills, contained deer and cow DNA, which could also violate some religious or cultural strictures. The study was published in the April 2012 issue of PLoS Genetics.

“This study demonstrates that deep sequencing via HTS is an efficient and cost-effective way to audit highly processed TCM products and will assist in monitoring their legality and safety, especially when plant reference databases become better established,” concluded lead author Michael Bunce, PhD. “It is hoped that this new approach to genetically audit medicinal products will bring about a new level of regulation to the area of complementary and alternative medicine. Auditing TCMs would assist in prosecuting individuals who seek to profit from the illegal trade in animal products.”

TCM has been practiced for thousands of years, but only within the last few decades has its use become more widespread outside of Asia. Concerns continue to be raised about the efficacy, legality, and safety of many popular complementary alternative medicines, including TCMs, ingredients of which are known to include derivatives of endangered, trade-restricted species of plants and animals, and therefore contravene the Convention on International Trade in Endangered Species (CITES) legislation.

Chromatographic studies have also detected the presence of heavy metals and plant toxins within some TCMs, and there are numerous cases of adverse reactions.

As of July 2012, all TCM practitioners in Australia must register with the new national Chinese Medicine Board of Australia, which will become part of the Australian Health Practitioner Regulation Agency (Canberra).

Related Links:

Murdoch University
Australian Health Practitioner Regulation Agency



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.